64x Bio

Brisbane, California, United States

Biotech Drug Discovery Preclinical Development

64x Bio is building a platform that radically increases the speed and scale of mammalian cell line discovery. Using a novel high throughput discovery and screening platform and an integrated computational design loop, we are developing new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specific focus on those used for cell and gene therapies. Our platform technology enables pharmaceutical and biotechnology companies to bring cell and gene therapies to patients more effectively, providing purpose-built genetically engineered cell lines to increase the efficiency of viral vector production and reduce the cost of manufacturing.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out 64x Bio on @MedStartr Today #DrugDevelopment #LifeSciences #Biotech #DrugDiscovery #PreclinicalDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/2Dv07GYTqJQ

Get Involved in 64x Bio

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: 64xbio.com/

Disease Areas

Drug Development Life Sciences

Technologies

Cell EngineeringPlatformBiotechnologyHigh-Throughput Production

🌐Website

What do you think of 64x Bio?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.